Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in “real-world” study: Experiences of the Polish Myeloma Group
Non-secretory multiple myeloma is a rare subtype of MM. This small study demonstrates that outcomes are comparable to secretory MM. However, the inclusion of this subset of patients in clinical trials is essential to assess prognosis, treatment efficacy and clinical outcomes.
Authors
- Grzegorz Charliński (ORCID: https://orcid.org/0000-0002-0595-5864)
- Anna Kopińska (ORCID: https://orcid.org/0000-0002-6821-7033)
- Elżbieta Wiater
- Martyna Podgajna (ORCID: https://orcid.org/0000-0002-2863-5142)
- Artur Jurczyszyn (ORCID: https://orcid.org/0000-0001-9796-8365)
- Łukasz Bołkuń (ORCID: https://orcid.org/0000-0002-6629-8626)
- Mateusz Krzystański
- Agata Tyczyńska (ORCID: https://orcid.org/0000-0002-2067-2715)
- Aneta Szudy‐Szczyrek (ORCID: https://orcid.org/0000-0003-2352-394X)
- Lidia Usnarska‐Zubkiewicz (ORCID: https://orcid.org/0000-0002-5893-1989)
- Michał Mielnik (ORCID: https://orcid.org/0000-0003-4473-5319)
- David H. Vesole
Institutions
- Medical University of Lublin (PL)
- Jagiellonian University (PL)
- Hackensack University Medical Center (US)
- Medical University of Białystok (PL)
- Medical University of Silesia (PL)
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
- Nicolaus Copernicus University (PL)
- Wroclaw Medical University (PL)
- University of Warmia and Mazury in Olsztyn (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2024-08-29
- DOI
- https://doi.org/10.17219/acem/189390
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00